ICYMI: Highlights From Patient-Centered Oncology Care®

You are a text condensation assistant.

Rules:
1. If the text length is already <= 8000 characters, return it unchanged.
2. If the text is longer, shorten it to <= 8000 characters while preserving its essential meaning, intent, and key information.
3. Remove secondary details, repetitions, and minor nuances, but keep the core message accurate.
4. Your output MUST NOT exceed 8000 characters.
5. Return ONLY the final condensed text. No explanations or comments.

TEXT:
The American Journal of Managed Care hosted its annual Patient Centered‑Oncology Care conference September 25–26, 2025, at the JW Marriott in Nashville. Themed “Finding Our Rhythm: Embracing Change in Oncology Care,” the meeting convened more than 60 faculty for panel discussions on clinical practice and policy.

AJMC provided live coverage of select sessions and recorded interviews with participating faculty; a full recap appears in Evidence‑Based Oncology.

5. Oncology experts highlighted advances including bispecific antibodies, cell and gene therapies, and clinical decision support tools, and noted growing interest in AI‑driven care. Interviewees included Vishnukamal Golla, MD, MPH; Ryan Haumschild, PharmD, MS, MBA, CPEL; and Scott Soefje, PharmD, MBA, BCOP.

4. Panels on AI emphasized that trust and transparency are essential to leveraging emerging technologies in precision oncology. Speakers discussed the implications for research and health‑care policy and the need for accountable deployment of AI in clinical workflows.

3. Oncology pharmacists were a focal point as panels explored the impact of rising drug costs and workforce shortages. Discussions addressed the increasing complexity of cancer therapies, growing demand for pharmacy expertise, and challenges in recruiting and retaining qualified staff.

2. Key takeaways from the conference included the importance of AI, continued innovation in therapies, and stronger collaboration among payers, providers, and manufacturers. Faculty noted opportunities to advance precision medicine and pathway development while cautioning about safe, equitable implementation of new technologies and treatments.

1. A panel on primary care–oncology collaboration underscored the need for better handoffs across the care continuum. Moderated by AJMC co–editor in chief A. Mark Fendrick, MD, the session highlighted challenges and opportunities from screening and diagnosis through treatment navigation to improve patient experience and continuity of care.

AJMC’s coverage of PCOC 2025 includes session recaps and interviews that expand on these themes.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *